Sequenom VP Inflated Down Syndrome Test: SEC
The U.S. Securities and Exchange Commission has filed a lawsuit alleging a former executive of Sequenom Inc. falsely claimed that a prenatal test the company made could predict with 100 percent...To view the full article, register now.
Already a subscriber? Click here to view full article